NASDAQ:CCCC

C4 Therapeutics Stock Nears Breakout Zone as Cancer-Drug Catalysts Put CCCC Back on Watch
····

C4 Therapeutics Stock Nears Breakout Zone as Cancer-Drug Catalysts Put CCCC Back on Watch

C4 Therapeutics shares traded at $3.74 before the Nasdaq open on May 28, holding gains after a 7.16% rise the prior session. The move comes as investors await cemsidomide updates at ASCO and EHA meetings. C4 reported $268.3 million in cash at March 31 and a narrowed Q1 net loss. The company expanded its Roche partnership in April, securing a $20 million upfront payment.
May 28, 2026

Stock Market Today

  • Why UK Cannabis Penny Shares Are Sparking Debate on AIM Market
    May 28, 2026, 9:03 AM EDT. UK cannabis penny shares listed on the AIM market have become a focal point of debate due to their volatility and speculative nature. These low-priced stocks, often representing small or emerging cannabis companies, attract risk-tolerant investors seeking high returns but also raise concerns about market manipulation and investor protection. Analysts and regulators are scrutinizing the market, emphasizing the importance of due diligence and caution amid growing interest in the cannabis sector. The debate reflects wider challenges in balancing innovation with oversight in London's junior market.